Collegium Pharmaceutical (COLL) EPS (Basic) Growth (1y) (2015 - 2026)
Collegium Pharmaceutical (COLL) EPS (Basic) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Collegium Pharmaceutical | 889.75 Mn | 740.43 Mn | 110.29 Mn | -223.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -223.09% |
| Mar 31, 2026 | 494.26% |
| Dec 31, 2025 | 37.74% |
| Sep 30, 2025 | 244.87% |
| Jun 30, 2025 | -37.69% |
| Mar 31, 2025 | -91.13% |
| Dec 31, 2024 | -58.97% |
| Sep 30, 2024 | -52.68% |
| Jun 30, 2024 | 60.91% |
| Mar 31, 2024 | 268.84% |
| Dec 31, 2023 | 544.83% |
| Sep 30, 2023 | 4,457.19% |
| Jun 30, 2023 | 346.08% |
| Mar 31, 2023 | -30.83% |
| Dec 31, 2022 | 70.30% |
| Sep 30, 2022 | -94.10% |
| Jun 30, 2022 | -107.28% |
| Mar 31, 2022 | -180.61% |
| Dec 31, 2021 | -454.34% |
| Sep 30, 2021 | -30.39% |